ECP, second drainage device effective in refractory glaucoma

ECP, second drainage device effective in refractory glaucoma

(HealthDay)—For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are effective as second surgeries, according to a study published online Aug. 28 in Clinical & Experimental Ophthalmology.

Yohko Murakami, M.D., from the University of California San Francisco, and colleagues conducted a nonrandomized retrospective chart review of with refractory glaucoma following a failed initial tube shunt. Patients underwent ECP (25 eyes) or GDD-2 with Baerveldt Glaucoma Implant (48 eyes) as a second surgery.

The researchers found that both ECP and GDD-2 correlated with significant reductions in intraocular pressure and number of antiglaucoma medications. At six and 12 months there were no significant differences in postoperative intraocular pressure or antiglaucoma medications between the groups. There were no between-group differences in survival outcomes.

"Both ECP and GDD-2 are both effective as second for refractory glaucoma that has failed a prior aqueous shunt," the authors write.


Explore further

Membrane-tube shunt device can reduce intraocular pressure

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: ECP, second drainage device effective in refractory glaucoma (2016, September 1) retrieved 7 August 2020 from https://medicalxpress.com/news/2016-09-ecp-drainage-device-effective-refractory.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments